サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1487505

医薬品とバイオテクノロジーにおけるAI市場：世界の産業分析、規模、シェア、成長、動向、2024-2034年予測

AI in Pharma and Biotech Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 139 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
医薬品とバイオテクノロジーにおけるAI市場：世界の産業分析、規模、シェア、成長、動向、2024-2034年予測
出版日: 2024年04月29日
発行: Transparency Market Research
ページ情報: 英文 139 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品とバイオテクノロジーにおけるAI市場- 調査範囲

TMRの調査レポート「医薬品とバイオテクノロジーにおけるAIの世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界の医薬品とバイオテクノロジーにおけるAI市場の収益と予測を提供します。また、2024年から2034年までの世界の医薬品とバイオテクノロジーにおけるAI市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連文書などを参照し、医薬品・バイオテクノロジー市場におけるAIを理解しました。

市場スナップショット
2023年の市場規模 18億米ドル
2034年の市場価値 131億米ドル
CAGR 18.8%

本レポートでは、世界の医薬品とバイオテクノロジーにおけるAI市場の競合情勢を掘り下げています。世界の医薬品・バイオテクノロジー分野のAI市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の医薬品とバイオテクノロジーにおけるAI市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 世界市場の分析と予測、2020年～2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主要M&A
  • COVID-19パンデミックの産業への影響

第6章 世界市場分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：用途別, 2020年～2034年
    • 創薬と医薬品開発
    • 臨床試験と最適化
    • 予測的メンテナンスと品質管理
    • 創薬ターゲットの同定
    • 疾病診断と予後予測
    • その他
  • 市場魅力度分析：用途別

第7章 世界市場分析・予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2020年～2034年
    • 製薬・バイオテクノロジー企業
    • 学術・受託研究機関
    • その他
  • 市場魅力度分析：エンドユーザー別

第8章 世界市場分析・予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2020年～2034年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第9章 北米市場の分析と予測

第10章 欧州市場の分析と予測

第11章 アジア太平洋市場の分析と予測

第12章 ラテンアメリカ市場の分析と予測

第13章 中東・アフリカ市場の分析と予測

第14章 競合情勢

  • 市場競合マトリックス（企業階層別・企業規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • BenevolentAI SA
    • Insilico Medicine
    • Recursion Pharmaceuticals
    • Atomwise Inc.
    • Berg LLC
    • Cloud Pharmaceuticals
    • Deep Genomics
    • Exscientia
    • Schrodinger
    • twoXar, Inc.
    • Insitro
図表

List of Tables

  • Table 01: Global AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 02: Global AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 03: Global AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 04: North America AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 05: North America AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 06: North America AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 07: Europe AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 08: Europe AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 09: Europe AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 10: Asia Pacific AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 11: Asia Pacific AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 12: Asia Pacific AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Latin America AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Latin America AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 15: Latin America AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 16: Middle East & Africa AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Middle East & Africa AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 18: Middle East & Africa AI in Pharma and Biotech Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global AI in Pharma and Biotech Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global AI in Pharma and Biotech Market Revenue (US$ Bn), by Application, 2023
  • Figure 03: Global AI in Pharma and Biotech Market Value Share, by Application, 2023
  • Figure 04: Global AI in Pharma and Biotech Market Revenue (US$ Bn), by End-user, 2023
  • Figure 05: Global AI in Pharma and Biotech Market Value Share, by End-user, 2023
  • Figure 06: Global AI in Pharma and Biotech Market Value Share, by Region, 2023
  • Figure 07: Global AI in Pharma and Biotech Market Value (US$ Bn) Forecast, 2023-2034
  • Figure 08: Global AI in Pharma and Biotech Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 09: Global AI in Pharma and Biotech Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 10: Global AI in Pharma and Biotech Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 11: Global AI in Pharma and Biotech Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 12: Global AI in Pharma and Biotech Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 13: Global AI in Pharma and Biotech Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 14: North America AI in Pharma and Biotech Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 15: North America AI in Pharma and Biotech Market Attractiveness Analysis, by Country, 2023-2034
  • Figure 16: North America AI in Pharma and Biotech Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 17: North America AI in Pharma and Biotech Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 18: North America AI in Pharma and Biotech Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 19: North America AI in Pharma and Biotech Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 20: North America AI in Pharma and Biotech Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 21: Europe AI in Pharma and Biotech Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 22: Europe AI in Pharma and Biotech Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 23: Europe AI in Pharma and Biotech Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 24: Europe AI in Pharma and Biotech Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 25: Europe AI in Pharma and Biotech Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 26: Europe AI in Pharma and Biotech Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 27: Europe AI in Pharma and Biotech Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 28: Asia Pacific AI in Pharma and Biotech Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 29: Asia Pacific AI in Pharma and Biotech Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 30: Asia Pacific AI in Pharma and Biotech Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 31: Asia Pacific AI in Pharma and Biotech Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 32: Asia Pacific AI in Pharma and Biotech Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 33: Asia Pacific AI in Pharma and Biotech Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 34: Asia Pacific AI in Pharma and Biotech Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 35: Latin America AI in Pharma and Biotech Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 36: Latin America AI in Pharma and Biotech Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 37: Latin America AI in Pharma and Biotech Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 38: Latin America AI in Pharma and Biotech Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 39: Latin America AI in Pharma and Biotech Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 40: Latin America AI in Pharma and Biotech Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 41: Latin America AI in Pharma and Biotech Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 42: Middle East & Africa AI in Pharma and Biotech Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 43: Middle East & Africa AI in Pharma and Biotech Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 44: Middle East & Africa AI in Pharma and Biotech Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 45: Middle East & Africa AI in Pharma and Biotech Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 46: Middle East & Africa AI in Pharma and Biotech Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 47: Middle East & Africa AI in Pharma and Biotech Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 48: Middle East & Africa AI in Pharma and Biotech Market Attractiveness Analysis, by End-user, 2023-2034
目次
Product Code: TMRGL79399

AI in Pharma and Biotech Market - Scope of Report

TMR's report on the global AI in pharma and biotech market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global AI in pharma and biotech market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global AI in pharma and biotech market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the AI in pharma and biotech market.

Market Snapshot
Market Value in 2023US$ 1.8 Bn
Market Value in 2034US$ 13.1 Bn
CAGR18.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global AI in pharma and biotech market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global AI in pharma and biotech market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global AI in pharma and biotech market.

The report delves into the competitive landscape of the global AI in pharma and biotech market. Key players operating in the global AI in pharma and biotech market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global AI in pharma and biotech market profiled in this report.

Key Questions Answered in Global AI in pharma and biotech Market Report:

  • What is the sales/revenue generated by AI in pharma and biotech across all regions during the forecast period?
  • What are the opportunities in the global AI in pharma and biotech market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

AI in Pharma and Biotech Market - Research Objectives and Research Approach

The comprehensive report on the global AI in pharma and biotech market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global AI in pharma and biotech market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global AI in pharma and biotech market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global AI in Pharma and Biotech Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global AI in Pharma and Biotech Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global AI in Pharma and Biotech Market Analysis and Forecast, by Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Application, 2020-2034
    • 6.3.1. Drug Discovery and Development
    • 6.3.2. Clinical Trials and Optimization
    • 6.3.3. Predictive Maintenance and Quality Control
    • 6.3.4. Drug Target Identification
    • 6.3.5. Disease Diagnosis & Prognosis
    • 6.3.6. Others
  • 6.4. Market Attractiveness Analysis, by Application

7. Global AI in Pharma and Biotech Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by End-user, 2020-2034
    • 7.3.1. Pharmaceutical & Biotech Companies
    • 7.3.2. Academic & Contract Research Organizations
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global AI in Pharma and Biotech Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region, 2020-2034
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America AI in Pharma and Biotech Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. Key Findings
  • 9.3. Market Value Forecast, by Application, 2020-2034
    • 9.3.1. Drug Discovery and Development
    • 9.3.2. Clinical Trials and Optimization
    • 9.3.3. Predictive Maintenance and Quality Control
    • 9.3.4. Drug Target Identification
    • 9.3.5. Disease Diagnosis & Prognosis
    • 9.3.6. Others
  • 9.4. Market Value Forecast, by End-user, 2020-2034
    • 9.4.1. Pharmaceutical & Biotech Companies
    • 9.4.2. Academic & Contract Research Organizations
    • 9.4.3. Others
  • 9.5. Market Value Forecast, by Country, 2020-2034
    • 9.5.1. U.S.
    • 9.5.2. Canada
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Application
    • 9.6.2. By End-user
    • 9.6.3. By Country

10. Europe AI in Pharma and Biotech Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Application, 2020-2034
    • 10.3.1. Drug Discovery and Development
    • 10.3.2. Clinical Trials and Optimization
    • 10.3.3. Predictive Maintenance and Quality Control
    • 10.3.4. Drug Target Identification
    • 10.3.5. Disease Diagnosis & Prognosis
    • 10.3.6. Others
  • 10.4. Market Value Forecast, by End-user, 2020-2034
    • 10.4.1. Pharmaceutical & Biotech Companies
    • 10.4.2. Academic & Contract Research Organizations
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 10.5.1. Germany
    • 10.5.2. U.K.
    • 10.5.3. France
    • 10.5.4. Italy
    • 10.5.5. Spain
    • 10.5.6. Rest of Europe
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Application
    • 10.6.2. By End-user
    • 10.6.3. By Country/Sub-region

11. Asia Pacific AI in Pharma and Biotech Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Application, 2020-2034
    • 11.3.1. Drug Discovery and Development
    • 11.3.2. Clinical Trials and Optimization
    • 11.3.3. Predictive Maintenance and Quality Control
    • 11.3.4. Drug Target Identification
    • 11.3.5. Disease Diagnosis & Prognosis
    • 11.3.6. Others
  • 11.4. Market Value Forecast, by End-user, 2020-2034
    • 11.4.1. Pharmaceutical & Biotech Companies
    • 11.4.2. Academic & Contract Research Organizations
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.5.1. China
    • 11.5.2. Japan
    • 11.5.3. India
    • 11.5.4. Australia & New Zealand
    • 11.5.5. Rest of Asia Pacific
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Application
    • 11.6.2. By End-user
    • 11.6.3. By Country/Sub-region

12. Latin America AI in Pharma and Biotech Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Application, 2020-2034
    • 12.3.1. Drug Discovery and Development
    • 12.3.2. Clinical Trials and Optimization
    • 12.3.3. Predictive Maintenance and Quality Control
    • 12.3.4. Drug Target Identification
    • 12.3.5. Disease Diagnosis & Prognosis
    • 12.3.6. Others
  • 12.4. Market Value Forecast, by End-user, 2020-2034
    • 12.4.1. Pharmaceutical & Biotech Companies
    • 12.4.2. Academic & Contract Research Organizations
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Application
    • 12.6.2. By End-user
    • 12.6.3. By Country/Sub-region

13. Middle East & Africa AI in Pharma and Biotech Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Application, 2020-2034
    • 13.3.1. Drug Discovery and Development
    • 13.3.2. Clinical Trials and Optimization
    • 13.3.3. Predictive Maintenance and Quality Control
    • 13.3.4. Drug Target Identification
    • 13.3.5. Disease Diagnosis & Prognosis
    • 13.3.6. Others
  • 13.4. Market Value Forecast, by End-user, 2020-2034
    • 13.4.1. Pharmaceutical & Biotech Companies
    • 13.4.2. Academic & Contract Research Organizations
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.5.1. GCC Countries
    • 13.5.2. South Africa
    • 13.5.3. Rest of Middle East & Africa
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Application
    • 13.6.2. By End-user
    • 13.6.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 14.2. Market Share Analysis, by Company (2023)
  • 14.3. Company Profiles
    • 14.3.1. BenevolentAI SA
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Financial Overview
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Insilico Medicine
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Financial Overview
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Recursion Pharmaceuticals
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Financial Overview
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Atomwise Inc.
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Financial Overview
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Berg LLC
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Financial Overview
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Cloud Pharmaceuticals
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Financial Overview
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Deep Genomics
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Financial Overview
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Exscientia
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Financial Overview
      • 14.3.8.5. Strategic Overview
    • 14.3.9. Schrodinger
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Financial Overview
      • 14.3.9.5. Strategic Overview
    • 14.3.10. twoXar, Inc.
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. SWOT Analysis
      • 14.3.10.4. Financial Overview
      • 14.3.10.5. Strategic Overview
    • 14.3.11. Insitro
      • 14.3.11.1. Company Overview
      • 14.3.11.2. Product Portfolio
      • 14.3.11.3. SWOT Analysis
      • 14.3.11.4. Financial Overview
      • 14.3.11.5. Strategic Overview